校正:患有异常性正常压力脑症的患者的认知特征和脆弱性
Magnhild S Dejgaard1,2, Per Kristian Eide2,3,4, Gro Gujord Tangen1,5
1Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
Frontiers in neurology
|October 30, 2025
概括
这项研究纠正了先前发表的一篇文章DOI. 修正后的DOI为10.3389/fneur.2025.1644507,确保准确引用和检索研究结果.
科学领域:
- 神经科学是一个神经科学.
- 医学研究 医学研究
背景情况:
- 之前的一篇文章包含了一个错误的文章DOI.
- 准确的引用对于科学完整性和研究可重复性至关重要.
研究的目的:
- 纠正已发表文章的数字物体标识符 (DOI).
- 确保研究人员能够准确地访问和引用预期的研究.
主要方法:
- 错误的DOI的识别.错误的DOI的识别.
- 通过数据库交叉引用验证正确的DOI.
主要成果:
- 该产品的正确DOI已经被确定为10.3389/fneur.2025.1644507.
- 这种纠正有助于正确引用和访问研究.
结论:
- 对DOI的纠正确保了科学记录的完整性.
- 准确的DOI对于研究成果的传播和影响至关重要.
相关概念视频
Cognitive Development During Adulthood
766
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
766
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


